You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 risk factors for receiving an inadequately dosed FQ prescription

From: Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

  Unadjusted Odds Ratio Adjusted Odds Ratio
Age
  < 1 years 0.249 (0.092–0.658) p = 0.005 0.263 (0.097–0.701) p = 0.008
 1–3 years 0.447 (0.198–0.976) p = 0.046 0.467 (0.206–1.027) p = 0.062
 3–6 years 0.269 (0.113–0.622) p = 0.002 0.254 (0.106–0.588) p = 0.020
 6–12 years 0.672 (0.281–1.605) p = 0.368 0.702 (0.292–1.684) p = 0.425
 12–18 years - (reference category) - (reference category)
 CF vs. non-CF 1.332 (0.398–3.992) p = 0.618
 IV vs. orally 0.816 (0.480–1.384) p = 0.451
 Study center 1.294 (0.753–2.253) p = 0.356
 Off-label vs. on-label indication 0.780 (0.357–1.597) p = 0.512
 Culture absent vs. present 1.292 (0.744–2.226) p = 0.358
 Other FQ vs. ciprofloxacin 3.566 (0.638–66.71) p = 0.234 2.601 (0.436–49.86) p = 0.382
Department
 Academic pediatrics ward 1.238 (0.686–2.248) p = 0.479  
 Oncology 1.213 (0.595–2.549) p = 0.601  
 PICU - (reference category)